FDA Approves Xeris Pharmaceuticals’ Glucagon to Treat Severe Hypoglycemia
On Tuesday, the type 1 diabetes (T1D) community got a helping hand in their ability to avoid severe hypoglycemia when…
Triple Therapy in T1D: Breakthrough T1D Researchers Launch a Clinical Trial
Since its discovery nearly 100 years ago, insulin has been the only effective treatment for type 1 diabetes (T1D). Improvements…
FDA Approves Baqsimi: The First Low Blood Sugar Treatment WITHOUT an Injection
Type 1 diabetes (T1D) can bring the fear of developing low blood sugar, called hypoglycemia, which can arise if someone…
ADA Scientific Sessions Recap—Day #3: Dan Finan, Ph.D.
There was some really amazing results out here in San Francisco! Here is Dan Finan, Ph.D., head of the Breakthrough…
Proof-of-Concept for Hypoglycemia Prevention
Hypoglycemia, or low blood sugar, can have serious effects, and it is, for most people with type 1 diabetes (T1D),…
Can a Snail Hold the Key to Better Blood Sugar Control?
Helena Safavi, Ph.D., of The University of Utah, decided to take an unusual and creative approach to ultra-rapid insulin development,…
SGLT Inhibition: It’s Not Just for Type 2 Anymore
Can a drug long-used for type 2 diabetes, also help those with T1D? The European body that approves medicines for…
GK Activator Clinical Trial Results
A protein, called glucokinase (or GK), acts as a key regulator of sugar levels in the body, and its expression…
An Important Step in the FDA Review of Sotagliflozin (Zynquista™) for T1D
You’ll hear it again and again: For some people with type 1 diabetes (T1D), SGLT inhibitor therapy* means taking less…
